Loading provider…
Loading provider…
Neurology Physician in Sacramento, CA
NPI: 1538357033Primary Practice Location
UNIVERSITY OF CALIFORNIA DAVIS MEDICAL CENTER
4301 X St, Sacramento, CA
Primary Employer
Regents of the Univ of CA
health.ucdavis.edu
HQ Phone
Get M.D. Michael's Phone Numberphone_androidMobile
Get M.D. Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2007 - 2027
MD State Medical License
1982 - 2007
Johns Hopkins University
Residency • Neurology
1984 - 1986
Residency • Neurology
1982 - 1983
Clinical Center at the National Institutes of Health
Residency • Neurology
1983 - 1984
Residency • Neurology
1981 - 1982
Yale-New Haven Medical Center (Waterbury)
Internship • Internal Medicine
1980 - 1981
Yale School of Medicine
medicine.yale.edu
Medical School
Until 1980
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 17 | 18 |
| 2 | 99215Established patient office or other outpatient, visit typically 40 minutes | 13 | 16 |
Tetrahydroaminoacridine blocks voltage-dependent ion channels in hippocampal neurons
Authors: Michael A. Rogawski
Publication Date: 1987-10
Dizocilpine-like Discriminative Stimulus Effects of Low-affinity Uncompetitive NMDA Antagonists
Authors: Kathleen A. Grant, Giancarlo Colombo, Julia D. Grant, Michael A. Rogawski
Publication Date: 1996-12
The Neuropharmacology of the Ketogenic Diet
Authors: Eileen Vining, Adam Hartman
Journal: Pediatr Neurol
Lead Sponsor: Michael A. Rogawski, MD, PhD
Collaborators: United States Department of Defense
Intervention / Treatment: DRUG: Placebo injection, DRUG: Allopregnanolone injection
Lead Sponsor: University of California, Davis
Collaborators: Forest Laboratories
Intervention / Treatment: DRUG: Placebo, DRUG: Memantine